Stockscreener 앱 받기
0.212
1.00%
0.0021
시간 외 거래:
.21
-0.002
-0.94%
Theriva Biologics Inc (TOVX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
100.00%
-
|
0.30 | - | - | - |
| Operating Expenses |
35.76%
3.295
|
2.427 | 2.063 | 4.44 | 13.13 |
| Operating Income/Loss |
54.91%
-3.295
|
-2.127 | -2.063 | -4.44 | -13.13 |
| Nonoperating Income/Loss |
6.02%
0.078
|
0.083 | 0.067 | 0.079 | 0.074 |
| Income/Loss From Continuing Operations Before Tax |
57.39%
-3.217
|
-2.044 | -1.996 | -4.361 | -13.06 |
| Net Income/Loss |
57.39%
-3.217
|
-2.044 | -1.996 | -4.361 | -13.06 |
| Basic Average Shares |
11.74%
45.89
|
41.07 | - | 9.6765 | 6.753 |
| Diluted Average Shares |
11.74%
45.89
|
41.07 | - | 9.6765 | 6.753 |
| Basic Earnings Per Share |
40.00%
-0.07
|
-0.05 | - | -0.45 | -1.93 |
| Diluted Earnings Per Share |
40.00%
-0.07
|
-0.05 | - | -0.45 | -1.93 |
1.35%
자본화:
|
볼륨(24시간):